drugset / Trial / NCT00729716

Comparison of BioCart™II With Microfracture for Treatment of Cartilage Defects of the Femoral Condyle

NCT00729716 ↗

Phase 2 Unknown 40 enrolled ProChon Biotech Ltd
RandomizedParallel-groupOpen-labelTreatment

Summary

BioCart™II is a novel scaffold seeded with autologous chondrocytes to be used to repair cartilage lesions of the knee. This study is designed to compare the efficacy and safety of BioCart™II treatment compared to microfracture which is the classical method of treatment.

Timeline

Start
2008-05
Primary completion
2012-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject BioCart™II Cell therapy — —

Indications